| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/04/1996 | EP0729516A1 Recombinant adenoviruses for gene therapy in cancers |
| 09/04/1996 | EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 09/04/1996 | EP0729509A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 09/04/1996 | EP0729508A1 Biological control agent comprising an isolated polyhedrosis virus |
| 09/04/1996 | EP0371119B1 Retroviral vector |
| 09/03/1996 | US5552310 Replication of hepatitis C virus genome and identification of virus having high infectivity |
| 08/29/1996 | WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 08/29/1996 | WO1996026281A1 Chimeric adenoviral fiber protein and methods of using same |
| 08/29/1996 | WO1996026267A1 Viral preparations, vectors, immunogens, and vaccines |
| 08/29/1996 | WO1996018737A3 Vectors and viruses for use in gene therapy |
| 08/29/1996 | CA2211743A1 Viral preparations, vectors, immunogens, and vaccines |
| 08/28/1996 | EP0728842A2 Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease |
| 08/28/1996 | EP0728214A1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 08/28/1996 | EP0728195A1 Methods for preserving recombinant viruses |
| 08/27/1996 | US5550051 Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen |
| 08/27/1996 | US5550018 Testing for presence of uridine to cytidine substitution at nucleotide position 472, comparing percentage of revertant viruses in unclassified vaccine to that in accepted reference attenuated by cytidine to uridine substitution |
| 08/22/1996 | WO1996025515A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
| 08/22/1996 | WO1996025506A1 Method for preparing a recombinant adenovirus genome |
| 08/22/1996 | CA2213116A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
| 08/21/1996 | EP0727484A1 Process for growing virus |
| 08/21/1996 | EP0727483A2 Retrovirus of the HIV-group and its application |
| 08/21/1996 | EP0727226A2 Process for removing viruses from protein solutions by ultrafiltration |
| 08/21/1996 | EP0726947A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
| 08/21/1996 | CN1129139A Use of azoles as virucidal agents in solutions of biologically active proteins |
| 08/20/1996 | US5547932 Transfection |
| 08/15/1996 | WO1996024663A1 Herpes simplex virus mutants |
| 08/15/1996 | WO1996024662A1 Process to 'in vitro' propagate the hepatitis c virus (hcv) in non lymphoblastoid animal cell cultures and products thereof |
| 08/15/1996 | WO1996013598A3 Hybrid adenovirus-aav virus and method of use thereof |
| 08/15/1996 | CA2212706A1 Herpes simplex virus mutants |
| 08/14/1996 | EP0725831A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 08/14/1996 | EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 08/14/1996 | EP0725791A1 Recombinant p53 adenovirus methods and compositions |
| 08/13/1996 | US5545726 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
| 08/13/1996 | US5545550 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore |
| 08/13/1996 | US5545516 Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light |
| 08/10/1996 | CA2169122A1 Removal of viruses from protein solutions by ultrafiltration |
| 08/08/1996 | WO1996015798A3 Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 08/07/1996 | EP0724643A1 Endosomolytically active particles |
| 08/06/1996 | US5543328 Adenoviruses having modified fiber proteins |
| 08/06/1996 | US5543131 HIV-2 strains capable of infecting humans and non-human primates, and infected non-human primates with immune system disease |
| 08/01/1996 | WO1996015231A3 Method for producing biologicals in protein-free culture |
| 07/31/1996 | EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/1996 | US5541100 Hiv, influenza |
| 07/25/1996 | WO1996022393A1 Improved method of selecting specific bacteriophages |
| 07/25/1996 | WO1996022378A1 Cells for the production of recombinant adenoviruses |
| 07/25/1996 | WO1996022363A1 Recombinant swinepox virus |
| 07/25/1996 | WO1996006177A3 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 07/25/1996 | CA2210567A1 Improved method of selecting specific bacteriophages |
| 07/25/1996 | CA2210168A1 Cells for the production of recombinant adenoviruses |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722493A1 Modified dna virus vectors and uses therefor |
| 07/24/1996 | EP0722337A1 Cd8?+ cell antiviral factor |
| 07/23/1996 | US5538856 Screening kit and method for diagnosing chronic immune dysfunction syndrome |
| 07/18/1996 | WO1996021727A1 Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens |
| 07/18/1996 | WO1996021671A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/18/1996 | WO1995026411A3 Composition and methods for creating syngeneic recombinant virus-producing cells |
| 07/18/1996 | CA2209941A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/16/1996 | CA2034489C Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 07/11/1996 | WO1996021043A1 Using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | WO1996021035A2 Retroviral delivery of full length factor viii |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021007A2 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
| 07/11/1996 | WO1996021006A1 Novel phosphoprotein secreted in the extracellular matrices of mammalian organs and methods for use thereof |
| 07/11/1996 | WO1996020592A1 Method for inactivating non-enveloped viruses using a viricide-potentiating agent |
| 07/11/1996 | CA2209523A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/10/1996 | EP0720851A2 Medicament for viral inactivation utilizing acridine or acridine derivatives |
| 07/10/1996 | EP0720654A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 07/10/1996 | CN1126491A Intracellular binding proteins and use thereof |
| 07/09/1996 | US5534597 Crosslinking a maleic anhydride copolymer with an a,w-diaminohydroxyalkane |
| 07/09/1996 | US5534439 Isolated DNA of human papillomavirus type 55 (HPV55) |
| 07/09/1996 | US5534430 Cell strain capable of multiplying an Epstein-Barr virus |
| 07/09/1996 | US5534413 Adherent and invasive mycoplasma |
| 07/04/1996 | WO1996020273A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0515433B1 Recombinant poxvirus internal cores |
| 07/02/1996 | US5532154 Mutated alpha virus |
| 07/02/1996 | US5532134 Mycoplasma diagnostic assay |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 07/01/1996 | CA2166371A1 Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease |
| 06/26/1996 | EP0717752A1 Therapeutic compounds |
| 06/26/1996 | EP0717636A1 Malaria recombinant poxvirus vaccine |
| 06/25/1996 | US5530195 Genetic engineering |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/20/1996 | WO1996018740A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | WO1996018737A2 Vectors and viruses for use in gene therapy |
| 06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | CA2208224A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
| 06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | CN1124928A Antibodies to P-selectin and their uses |
| 06/18/1996 | US5527669 Oligonucleotide primers used to amplify and detect virus via reverse transcription |
| 06/18/1996 | US5527666 Method for the diagnosis in vitro of HIV-1 virus infections |
| 06/18/1996 | CA2071954C Matrix with adherently bound cells and process for producing viruses/virus antigens |
| 06/13/1996 | WO1996017961A1 Method and apparatus for detecting bacteria |